Liquid biopsy: new cancer test ‘is holy grail’ of early detection
Simple blood test may save countless lives by enabling diagnosis years before symptoms appear
A new blood test with the potential to detect up to ten different cancers long before any symptoms appear may be available on the NHS within five years, scientists have announced.
The procedure, known as a liquid biopsy, is being hailed as a major breakthrough in cancer treatment, after trials on more than 1,600 patients found that the test worked with up to 90% accuracy.
“This is potentially the holy grail of cancer research, to find cancers that are currently hard to cure at an earlier stage when they are easier to cure,” said lead study author Dr Eric Klein, from the Cleveland Clinic’s Taussig Cancer Institute, in Ohio. “We hope this test could save many lives.”
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The test screens for the disease by detecting tiny fragments of DNA released by cancer cells into the bloodstream. The research - presented at the annual conference of the American Society of Clinical Oncologists, in Chicago - found that the procedure was particularly effective for spotting ovarian and pancreatic cancers.
However, the number of patients in whom cancers were detected in the trials was small. For example, although the test was able to detect ovarian cancer with 90% accuracy, only ten ovarian cancers in total were detected, The Guardian reports.
Nonetheless, liquid biopsies could “dramatically reshape the way that care for cancer and other inherited diseases is delivered”, says The Independent.
Simon Stevens, chief executive of NHS England, said the test has the potential to “unlock enormous survival gains” across the NHS.
“As the NHS marks its 70th anniversary, we stand on the cusp of a new era of personalised medicine that will dramatically transform care for cancer and for inherited and rare diseases,” he added.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
'It may not be surprising that creative work is used without permission'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
5 simple items to help make your airplane seat more comfortable
The Week Recommends Gel cushions and inflatable travel pillows make a world of difference
By Catherine Garcia, The Week US Published
-
How safe are cruise ships in storms?
The Explainer The vessels are always prepared
By Devika Rao, The Week US Published
-
A 'transformative' gene therapy for haemophilia B
The Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost
By Julia O'Driscoll, The Week UK Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Infected blood scandal: will justice be served?
Today's Big Question Government apologises for 'decades-long moral failure' and promises £10bn compensation but true accountability may take far longer
By Harriet Marsden, The Week UK Published
-
Immunotherapy and hay fever
The Explainer Research shows that the treatment could provide significant relief from symptoms for many hay fever sufferers
By Richard Windsor, The Week UK Published
-
The pros and cons of universal health care
Pros and Cons A medical system that serves everyone comes with its own costs, and they're not only financial
By Rebecca Messina, The Week UK Last updated
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
By Devika Rao, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
'Beyond belief': fears of asbestos return
Under the radar Attention is returning to the dangers of the carcinogenic substance
By Chas Newkey-Burden, The Week UK Published